What are the 7 nitrosamine impurities?
The seven commonly identified small-molecule nitrosamine impurities in pharmaceuticals are NDMA (N-Nitrosodimethylamine), NDEA (N-Nitrosodiethylamine), NMBA (N-Nitroso-N-methyl-4-aminobutyric acid), NIPEA (N-Nitrosoisopropylethylamine), NDIPA (N-Nitrosodiisopropylamine), NDBA (N-Nitrosodibutylamine), and NMPA (N-Nitrosomethylphenylamine).
Pharmaceutical manufacturers need to identify, monitor, and control these impurities to maintain product quality and meet regulatory requirements. Proper Nitrosamine Impurity Testing helps detect and quantify nitrosamine levels using suitable analytical techniques. Professional Nitrosamine Testing Services also support risk assessment and regulatory compliance by identifying potential Nitrosamine Impurities in Pharmaceuticals. Regular testing and effective quality control measures help manufacturers maintain safer medicines and follow applicable FDA and EMA guidelines. Read the full guide: https://www.molkem.com/blog/nitrosamine-acceptable-intake-limits